Clinical Trial Update: BXOS110 Injection in the Treatment of Acute Ischaemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BXOS110 injection in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• BXOS110

Snippet

Sponsor: Biocells (Beijing) Biotech Co.,Ltd | Conditions: Acute Ischemic Stroke | Phase 2 | Status: UNKNOWN